Microbiota of the first-pass meconium and subsequent atopic and allergic disorders in children

Katja Kielenniva1, Sofia Ainonen1, Petri Vänni2,3

  • 1PEDEGO (Pediatrics, Dermatology, Gynecology, Obstetrics) Research Unit and Medical Research Center Oulu, University of Oulu, Oulu, Finland.

Insights

The first gut microbiota in meconium was not linked to allergy development in children by age four. Further research is needed to confirm if early gut bacteria influence childhood allergic diseases.

Area of Science:

  • Microbiome research
  • Pediatric allergy
  • Gut health

Background:

  • Emerging cohort studies suggest a link between gut microbiota composition and childhood allergic diseases.
  • The first-pass meconium represents the initial gut microbiota, yet its role in allergic disease development remains largely unexplored.

Purpose of the Study:

  • To investigate the association between the bacterial composition of first-pass meconium and the development of allergic diseases up to four years of age.

Main Methods:

  • A prospective birth cohort study design was employed.
  • Bacterial 16S rRNA gene amplicon sequencing was used to analyze meconium microbiota composition.
  • Allergic diseases were assessed up to age four using standardized questionnaires via online surveys or telephone.

Main Results:

  • Meconium microbiota diversity and composition showed no association with atopic eczema, wheezing, or cow's milk allergy by age four.
  • Principal components analysis did not reveal distinct meconium microbiome clusters related to wheezing or cow's milk allergy.

Conclusions:

  • No evidence was found linking first-pass meconium gut microbiota composition to atopic manifestations by age four.
  • Larger-scale studies are recommended to definitively rule out any potential relationship between early meconium microbiota and childhood allergies.
Abstract